137 related articles for article (PubMed ID: 7494339)
1. The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon.
Ozmen L; Aguet M; Trinchieri G; Garotta G
J Virol; 1995 Dec; 69(12):8147-50. PubMed ID: 7494339
[TBL] [Abstract][Full Text] [Related]
2. The gamma interferon (IFN-gamma) mimetic peptide IFN-gamma (95-133) prevents encephalomyocarditis virus infection both in tissue culture and in mice.
Mujtaba MG; Patel CB; Patel RA; Flowers LO; Burkhart MA; Waiboci LW; Martin J; Haider MI; Ahmed CM; Johnson HM
Clin Vaccine Immunol; 2006 Aug; 13(8):944-52. PubMed ID: 16893996
[TBL] [Abstract][Full Text] [Related]
3. Innate immune response to encephalomyocarditis virus infection mediated by CD1d.
Exley MA; Bigley NJ; Cheng O; Shaulov A; Tahir SM; Carter QL; Garcia J; Wang C; Patten K; Stills HF; Alt FW; Snapper SB; Balk SP
Immunology; 2003 Dec; 110(4):519-26. PubMed ID: 14632651
[TBL] [Abstract][Full Text] [Related]
4. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice.
Schijns VE; Haagmans BL; Horzinek MC
J Immunol; 1995 Sep; 155(5):2525-32. PubMed ID: 7650382
[TBL] [Abstract][Full Text] [Related]
5. IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways.
Yu WG; Ogawa M; Mu J; Umehara K; Tsujimura T; Fujiwara H; Hamaoka T
J Leukoc Biol; 1997 Oct; 62(4):450-7. PubMed ID: 9335314
[TBL] [Abstract][Full Text] [Related]
6. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
Ilyinskii PO; Wang R; Balk SP; Exley MA
J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
[TBL] [Abstract][Full Text] [Related]
7. A pivotal role for interferon-gamma in protection against group A streptococcal skin infection.
Raeder RH; Barker-Merrill L; Lester T; Boyle MD; Metzger DW
J Infect Dis; 2000 Feb; 181(2):639-45. PubMed ID: 10669349
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo recovery of IFN-gamma, but not IL-2, production by IL-12 in mice with plasma cell tumors.
Ruzek MC; Mathur A
Int Immunol; 1996 Mar; 8(3):413-22. PubMed ID: 8671628
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
Nishio R; Shioi T; Sasayama S; Matsumori A
J Am Coll Cardiol; 2003 Jan; 41(2):340-5. PubMed ID: 12535832
[TBL] [Abstract][Full Text] [Related]
10. In vivo antiviral activity of recombinant murine gamma interferon.
Shalaby MR; Hamilton EB; Benninger AH; Marafino BJ
J Interferon Res; 1985; 5(2):339-45. PubMed ID: 2989389
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
Silva JS; Morrissey PJ; Grabstein KH; Mohler KM; Anderson D; Reed SG
J Exp Med; 1992 Jan; 175(1):169-74. PubMed ID: 1730915
[TBL] [Abstract][Full Text] [Related]
12. Enhancement by muramyl peptides of the protective response of interferon-alpha/beta against encephalomyocarditis virus infection.
Pouillart PR; Audibert FM; Chedid LA; Lefrancier PL; Bahr GM
Int J Immunopharmacol; 1996 Mar; 18(3):183-92. PubMed ID: 8796446
[TBL] [Abstract][Full Text] [Related]
13. Regulation of macrophage growth and antiviral activity by interferon-gamma.
Goldberg M; Belkowski LS; Bloom BR
J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
[TBL] [Abstract][Full Text] [Related]
14. Protective role of interleukin-12 in viral myocarditis.
Shioi T; Matsumori A; Nishio R; Ono K; Kakio T; Sasayama S
J Mol Cell Cardiol; 1997 Sep; 29(9):2327-34. PubMed ID: 9299356
[TBL] [Abstract][Full Text] [Related]
15. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
[TBL] [Abstract][Full Text] [Related]
16. [Antiviral activity of oral ultralow doses of antibodies to gamma-interferon: experimental study of influenza infection in mice].
Sergeev AN; P'iankov OV; Shishkina LN; Duben' LG; Petrishchenko VA; Zhukov VA; P'iankova OG; Sviatchenko LI; Sherstoboev EIu; Karimova TV; Martiushev-Poklad AV; Sergeeva SA; Epshteĭn OI; Glotov AG; Glotova TI
Antibiot Khimioter; 2004; 49(11):7-11. PubMed ID: 15945542
[TBL] [Abstract][Full Text] [Related]
17. Natural human antibodies to gamma interferon interfere with the immunomodulating activity of the lymphokine.
Turano A; Balsari A; Viani E; Landolfo S; Zanoni L; Gargiulo F; Caruso A
Proc Natl Acad Sci U S A; 1992 May; 89(10):4447-51. PubMed ID: 1316609
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of in vitro immunoglobulin production by IL-12 in murine chronic graft-vs.-host disease: synergism with IL-18.
Lauwerys BR; Renauld JC; Houssiau FA
Eur J Immunol; 1998 Jun; 28(6):2017-24. PubMed ID: 9645383
[TBL] [Abstract][Full Text] [Related]
19. In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).
Gazzinelli RT; Giese NA; Morse HC
J Exp Med; 1994 Dec; 180(6):2199-208. PubMed ID: 7964495
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.
Kawamoto S; Oritani K; Asada H; Takahashi I; Ishikawa J; Yoshida H; Yamada M; Ishida N; Ujiie H; Masaie H; Tomiyama Y; Matsuzawa Y
J Virol; 2003 Sep; 77(17):9622-31. PubMed ID: 12915574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
